Boucau J - Search Results

1

HIV Controllers Exhibit Effective CD8⁺ T Cell Recognition of HIV-1-Infected Non-activated CD4⁺ T Cells.

Monel B, McKeon A, Lamothe-Molina P, Jani P, Boucau J, Pacheco Y, Jones RB, Le Gall S, Walker BD. Monel B, et al. Among authors: boucau j. Cell Rep. 2019 Apr 2;27(1):142-153.e4. doi: 10.1016/j.celrep.2019.03.016. Cell Rep. 2019. PMID: 30943397 Free PMC article.

2

HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.

Balamurugan A, Ali A, Boucau J, Le Gall S, Ng HL, Yang OO. Balamurugan A, et al. Among authors: boucau j. J Virol. 2013 Aug;87(15):8726-34. doi: 10.1128/JVI.01040-13. Epub 2013 Jun 5. J Virol. 2013. PMID: 23740989 Free PMC article.

3

A simple methodology to assess endolysosomal protease activity involved in antigen processing in human primary cells.

Vaithilingam A, Lai NY, Duong E, Boucau J, Xu Y, Shimada M, Gandhi M, Le Gall S. Vaithilingam A, et al. Among authors: boucau j. BMC Cell Biol. 2013 Aug 9;14:35. doi: 10.1186/1471-2121-14-35. BMC Cell Biol. 2013. PMID: 23937268 Free PMC article.

4

A real-time killing assay to follow viral epitope presentation to CD8 T cells.

Gourdain P, Boucau J, Kourjian G, Lai NY, Duong E, Le Gall S. Gourdain P, et al. Among authors: boucau j. J Immunol Methods. 2013 Dec 15;398-399:60-7. doi: 10.1016/j.jim.2013.09.009. Epub 2013 Sep 20. J Immunol Methods. 2013. PMID: 24060536 Free PMC article. Clinical Trial.

5

Mechanisms of HIV protein degradation into epitopes: implications for vaccine design.

Rucevic M, Boucau J, Dinter J, Kourjian G, Le Gall S. Rucevic M, et al. Among authors: boucau j. Viruses. 2014 Aug 21;6(8):3271-92. doi: 10.3390/v6083271. Viruses. 2014. PMID: 25196483 Free PMC article. Review.

6

A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.

Davis ZB, Cogswell A, Scott H, Mertsching A, Boucau J, Wambua D, Le Gall S, Planelles V, Campbell KS, Barker E. Davis ZB, et al. Among authors: boucau j. PLoS Pathog. 2016 Feb 1;12(2):e1005421. doi: 10.1371/journal.ppat.1005421. eCollection 2016 Feb. PLoS Pathog. 2016. PMID: 26828202 Free PMC article.

7

HIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation.

Kourjian G, Rucevic M, Berberich MJ, Dinter J, Wambua D, Boucau J, Le Gall S. Kourjian G, et al. Among authors: boucau j. J Immunol. 2016 May 1;196(9):3595-607. doi: 10.4049/jimmunol.1600055. Epub 2016 Mar 23. J Immunol. 2016. PMID: 27009491 Free PMC article.

8

Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.

Rucevic M, Kourjian G, Boucau J, Blatnik R, Garcia Bertran W, Berberich MJ, Walker BD, Riemer AB, Le Gall S. Rucevic M, et al. Among authors: boucau j. J Virol. 2016 Sep 12;90(19):8605-20. doi: 10.1128/JVI.00599-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27440904 Free PMC article.

9

Antigen processing and presentation in HIV infection.

Boucau J, Le Gall S. Boucau J, et al. Mol Immunol. 2019 Sep;113:67-74. doi: 10.1016/j.molimm.2018.03.027. Epub 2018 Apr 7. Mol Immunol. 2019. PMID: 29636181 Free PMC article. Review.

10

The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.

Boucau J, Madouasse J, Kourjian G, Carlin CS, Wambua D, Berberich MJ, Le Gall S. Boucau J, et al. J Immunol. 2019 May 15;202(10):2856-2872. doi: 10.4049/jimmunol.1700950. Epub 2019 Apr 1. J Immunol. 2019. PMID: 30936293 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters